Aura Biosciences, Inc. (AURA)
$6.54+0.46%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $420M
- Beta
- 0.41
- P/E (TTM)
- -3.47
- Short % float
- 23.17%
- Days to cover
- 9.2
- SI change
- +47.0%
- 1W
- +7.39%
- 1M
- -6.44%
- vs SPY 1W
- +6.23%
- vs SPY 1M
- -9.43%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on AURA?
- LOPJLB’s latest quantitative signal on Aura Biosciences, Inc. (AURA) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is AURA in?
- Aura Biosciences, Inc. (AURA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Aura Biosciences, Inc. (AURA) do?
- Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-…